Correction to the Abstract: Positive Predictive Value Confidence Interval for AI-Assisted Detection of Subclinical Basal Cell Carcinoma
-
October 1, 2026
Clinical Report: Correction to the Abstract on AI-Assisted BCC Detection
Overview
The abstract for the original investigation of AI-assisted line-field confocal optical coherence tomography (LC-OCT) to detect subclinical basal cell carcinoma (BCC) contained an error in the reported confidence interval. The corrected 95% confidence interval for a positive predictive value of 83.3% is 58.6%–96.4%; the article has been corrected online.
Background
The abstract of the original investigation, “AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma,” contained an error in the reported confidence interval.
Data Highlights
| Measure | Corrected result |
|---|---|
| Positive predictive value | 83.3% |
| 95% confidence interval | 58.6%–96.4% |
| Correction status | Article corrected online |
Key Findings
- The abstract of the original investigation contained an error in the reported confidence interval.
- For a positive predictive value of 83.3%, the corrected 95% confidence interval is 58.6%–96.4%.
- The article appeared online August 19, 2026, and has been corrected online.
Clinical Implications
Readers interpreting the study’s abstract should use the corrected 95% confidence interval of 58.6%–96.4% for the reported 83.3% positive predictive value. The source states that the article has been corrected online.
Conclusion
The correction updates the confidence interval accompanying the reported positive predictive value for AI-assisted LC-OCT detection of subclinical BCC. The corrected article is available online.
Related Resources & Content
- Original Investigation, JAMA Dermatology — AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma
- AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma
- AI-Assisted LC-OCT Detects Subclinical Basal Cell Carcinomas in High-Risk Patients
- S1 guideline for imaging diagnostics for skin diseases
- S1 guideline for imaging diagnostics for skin diseases - PMC
- AI-Assisted Line-Field Confocal Optical Coherence Tomography to Detect Subclinical Basal Cell Carcinoma.
- Diagnostic accuracy of noninvasive optical imaging for basal cell carcinoma: A systematic review and meta-analysis.
Based on findings from:
Error in Abstract
Jama Dermatology, 2026.
https://jamanetwork.com/journals/jamadermatology/fullarticle/2855631
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
